.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

LUNESTA Drug Profile

« Back to Dashboard
Lunesta is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from eleven suppliers.

The generic ingredient in LUNESTA is eszopiclone. There are twenty drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.

Summary for Tradename: LUNESTA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list11

Clinical Trials for: LUNESTA

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-001Dec 15, 2004RXNo<disabled><disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-002Dec 15, 2004RXNo<disabled><disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-001Dec 15, 2004RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LUNESTA

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-002Dec 15, 20046,319,926*PED<disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-002Dec 15, 20046,444,673*PED<disabled>
Sunovion Pharms Inc
LUNESTA
eszopiclone
TABLET;ORAL021476-002Dec 15, 20046,864,257*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LUNESTA

Drugname Dosage Strength RLD Submissiondate
eszopicloneTablets1 mg, 2 mg and 3 mgLunesta12/15/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc